Reports on the use of a transdermal therapeutic system containing buprenorphine to manage pain. Avoidance of gastrointestinal passage and first-pass metabolism; Continuous slow release of buprenorphine at a defined rate from its polymer matrix into the blood; Efficacy and safety of transdermal buprenorphine.